House Bill 750 appropriates $2.5 million in recurring General Fund dollars each year of the 2025-2027 biennium to the Department of Health and Human Services, Division of Public Health, for competitive grants to nonprofit community health centers. The grants must be used to purchase and provide long-acting reversible contraceptives (LARCs) to underserved, uninsured, or medically indigent patients. The bill defines LARCs as FDA-approved contraceptive drugs or devices that provide effective, temporary birth control over an extended period without requiring ongoing user action and that are prescribed by an authorized health care provider.
The bill would take effect July 1, 2025. In practical terms, it creates a state-funded program to expand access to contraception through community health centers, with the goal of reducing barriers related to cost and insurance coverage for low-income patients. It does not appear to amend existing health statutes broadly, but it does direct DHHS to administer a new grant program and spend recurring appropriations for this purpose.
HB750 would add a recurring appropriation and a new grant program within DHHS’s Division of Public Health, directing state funds to nonprofit community health centers for the purchase and distribution of LARCs. Its legal effect is primarily fiscal and administrative: it creates a state-supported funding stream for contraceptive access rather than changing eligibility rules, insurance mandates, or provider licensing requirements. The bill would affect DHHS, nonprofit community health centers, and underserved patients who rely on those centers for reproductive health services.
No committee transcript or recorded vote information is available, so there is no documented floor or committee debate to gauge sentiment. Based on the bill’s sponsorship and structure, it appears to be framed as a public health and access-to-care measure aimed at helping low-income and uninsured patients obtain contraception. The absence of recorded opposition or amendments in the provided materials means the overall sentiment cannot be assessed beyond the bill’s stated policy purpose.
The main potential point of contention is the use of recurring state General Fund dollars for contraception-related services, which may draw differing views on budget priorities and reproductive health policy. Supporters are likely to emphasize access, preventive care, and reduced cost barriers for underserved patients, while critics may object on fiscal grounds or on ideological grounds related to contraception funding. Because no committee discussion or vote record is provided, no specific legislator or stakeholder positions can be identified from the available materials.